Differences in the immunogenicity of heterologous Ad26.COV.2/BNT162b2 vaccination compared to other heterologous and homologous COVID-19 vaccine regimens

被引：0
|
作者：
Klemis, V. [1 ]
Venhorst, A. [2 ]
Halmans, L. [2 ]
Schmidt, T. [1 ]
Greiss, F. [3 ]
Wilhelm, A. [4 ]
Widera, M. [4 ]
Sester, U. [5 ]
Gaertner, B. C. [6 ]
Meyer, T. [2 ]
Sester, M. [1 ]
机构：
[1] Saarland Univ, Dept Transplant & Infect Immunol, Homburg, Germany
[2] Saarland Univ, Inst Sports & Prevent Med, Saarbrucken, Germany
[3] Humboldt Univ, Dept Sports Med, Berlin, Germany
[4] Goethe Univ Frankfurt, Inst Med Virol, Frankfurt, Germany
[5] SHG Klinikum Volklingen, Dept Nephrol, Volklingen, Germany
[6] Saarland Univ, Inst Med Microbiol & Hyg, Homburg, Germany
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2022年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P 019
引用
收藏
页码：165 / 166
页数：2
相关论文
共 50 条
  • [31] BNT162b2 mRNA Covid-19 Vaccine - in a Nationwide Mass Vaccination Setting
    Roest, Stefan
    Hoek, Rogier A. S.
    Manintveld, Olivier C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (20): : 1968 - 1970
  • [32] BNT162b2 Vaccine Booster and Covid-19 Mortality
    Rohban, Thomas
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (10): : 1000 - 1000
  • [33] Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine
    Saito, Kazuyuki
    Shimizu, Taro
    Suzuki-Inoue, Katsue
    Ishida, Tatsuhiro
    Wada, Yoshiaki
    NEUROLOGICAL SCIENCES, 2021, 42 (11) : 4433 - 4435
  • [34] Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine
    Kazuyuki Saito
    Taro Shimizu
    Katsue Suzuki-Inoue
    Tatsuhiro Ishida
    Yoshiaki Wada
    Neurological Sciences, 2021, 42 : 4433 - 4435
  • [35] Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients
    Havlin, Jan
    Svorcova, Monika
    Dvorackova, Eliska
    Lastovicka, Jan
    Lischke, Robert
    Kalina, Tomas
    Hubacek, Petr
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (08): : 754 - 758
  • [36] Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination
    Barocci, Simone
    Orlandi, Chiara
    Diotallevi, Aurora
    Buffi, Gloria
    Ceccarelli, Marcello
    Vandini, Daniela
    Carlotti, Eugenio
    Galluzzi, Luca
    Rocchi, Marco Bruno Luigi
    Magnani, Mauro
    Casabianca, Anna
    VACCINES, 2022, 10 (04)
  • [37] Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination
    Hammerschmidt, Swantje I.
    Bosnjak, Berislav
    Bernhardt, Guenter
    Friedrichsen, Michaela
    Ravens, Inga
    Dopfer-Jablonka, Alexandra
    Hoffmann, Markus
    Pohlmann, Stefan
    Behrens, Georg M. N.
    Foerster, Reinhold
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (10) : 2455 - 2456
  • [38] Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trial
    Janssen, Cecile
    Cachanado, Marine
    Ninove, Laetitia
    Lachatre, Marie
    Michon, Jocelyn
    Epaulard, Olivier
    Maakaroun-Vermesse, Zoha
    Chidiac, Christian
    Laviolle, Bruno
    Aumaitre, Hugues
    Assaf, Ady
    Lacombe, Karine
    Schmidt-Mutter, Catherine
    Botelho-Nevers, Elisabeth
    Briere, Magali
    Boisson, Thomas
    Loubet, Paul
    Bienvenu, Boris
    Bouchaud, Olivier
    Touati, Amel
    Pereira, Christine
    Rousseau, Alexandra
    Berard, Laurence
    Montil, Melissa
    de Lamballerie, Xavier
    Simon, Tabassome
    Launay, Odile
    ECLINICALMEDICINE, 2022, 48
  • [39] Immunogenicity and efficacy of heterologous ChAdOx1-BNT162b2 vaccination
    Pozzetto, Bruno
    Legros, Vincent
    Djebali, Sophia
    Barateau, Veronique
    Guibert, Nicolas
    Villard, Marine
    Peyrot, Loic
    Allatif, Omran
    Fassier, Jean-Baptiste
    Massardier-Pilonchery, Amelie
    Brengel-Pesce, Karen
    Yaugel-Novoa, Melyssa
    Denolly, Solene
    Boson, Bertrand
    Bourlet, Thomas
    Bal, Antonin
    Valette, Martine
    Andrieu, Thibault
    Lina, Bruno
    Cosset, Francois-Loic
    Paul, Stephane
    Defrance, Thierry
    Marvel, Jacqueline
    Walzer, Thierry
    Trouillet-Assant, Sophie
    NATURE, 2021, 600 (7890) : 701 - +
  • [40] Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination
    Swantje I. Hammerschmidt
    Berislav Bosnjak
    Günter Bernhardt
    Michaela Friedrichsen
    Inga Ravens
    Alexandra Dopfer-Jablonka
    Markus Hoffmann
    Stefan Pöhlmann
    Georg M. N. Behrens
    Reinhold Förster
    Cellular & Molecular Immunology, 2021, 18 : 2455 - 2456
12345